AdaptHealth (AHCO) Capital Expenditures Growth (1y) (2020 - 2026)
AdaptHealth (AHCO) Capital Expenditures Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -47.73% |
| 10 | AdaptHealth | 1.49 Bn | 1.45 Bn | 111.50 Mn | 7.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.24% |
| Dec 31, 2025 | 1,004.92% |
| Sep 30, 2025 | 176.97% |
| Jun 30, 2025 | -30.23% |
| Mar 31, 2025 | 127.18% |
| Dec 31, 2024 | 104.42% |
| Sep 30, 2024 | -258.84% |
| Jun 30, 2024 | -7.09% |
| Mar 31, 2024 | 20.42% |
| Dec 31, 2023 | -699.27% |
| Sep 30, 2023 | 174.50% |
| Jun 30, 2023 | 77.25% |
| Mar 31, 2023 | -54.72% |
| Dec 31, 2022 | -113.98% |
| Sep 30, 2022 | -55.12% |
| Jun 30, 2022 | 76.20% |
| Mar 31, 2022 | 116.78% |
| Dec 31, 2021 | 1,026.53% |
| Sep 30, 2021 | -521.03% |
| Jun 30, 2021 | 8,151.47% |